{"id":3540,"date":"2026-05-04T04:08:28","date_gmt":"2026-05-04T04:08:28","guid":{"rendered":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/"},"modified":"2026-05-04T05:30:11","modified_gmt":"2026-05-04T05:30:11","slug":"research-and-development-capitalisation","status":"publish","type":"post","link":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/","title":{"rendered":"Research and Development Capitalisation"},"content":{"rendered":"

Research and development capitalisation means treating R&D spending as a long-term investment rather than a short-term expense, and in equity research<\/strong> it is used by analysts to better reflect true business value, improve equity valuation<\/strong>, and generate more accurate investment insights<\/strong>.<\/p>\n

Why R&D Is Expensed in Financial Accounting<\/h3>\n

Under standard financial accounting<\/strong>, most R&D costs are expensed immediately in financial reports<\/strong> and audit reports<\/strong>. This is done because the future benefits of R&D are uncertain and difficult to measure at the time of spending.<\/p>\n

However, this creates a mismatch. Many companies, especially in technology and pharmaceuticals, rely heavily on R&D to drive growth. Expensing these costs reduces current earnings and distorts profitability analysis<\/strong>, even though the spending builds long-term value.<\/p>\n

For investment analysts<\/strong>, this leads to gaps in equity analysis<\/strong> and weakens the reliability of equity research reports<\/strong>.<\/p>\n

What R&D Capitalisation Means in Equity Research<\/h3>\n

In investment research<\/strong>, analysts often adjust for this issue by capitalising R&D. This means treating R&D spending as an asse<\/a>t and spreading its cost over several years, similar to depreciation.<\/p>\n

This approach aligns R&D with its economic purpose. Instead of reducing earnings in a single period, the cost is allocated over the period during which the benefits are expected to occur.<\/p>\n

This adjustment improves financial modeling<\/strong>, supports better financial forecasting<\/strong>, and leads to more accurate equity valuation<\/strong>.<\/p>\n

How Analysts Capitalise R&D<\/h3>\n

The process of capitalising R&D involves several steps. First, analysts estimate the useful life of R&D investments. This could range from three to ten years depending on the industry.<\/p>\n

Next, historical R&D expenses are accumulated to create a notional asset. This asset is then amortised over its estimated life.<\/p>\n

These adjustments are incorporated into financial modeling<\/strong>, affecting metrics such as revenue projections<\/strong>, margins, and enterprise value<\/strong>. This leads to improved performance measurement<\/strong> and more meaningful ratio analysis<\/strong>.<\/p>\n

For portfolio managers<\/strong>, asset managers<\/strong>, and wealth managers<\/strong>, these adjustments provide clearer portfolio insights<\/strong>.<\/p>\n

Impact on Ratio Analysis<\/h3>\n

Capitalising R&D has a significant impact on ratio analysis<\/strong>. When R&D is treated as an asset, the asset base increases, which affects return metrics.<\/p>\n

For example, return on assets becomes more realistic because the denominator reflects the true level of investment. Similarly, adjusted earnings provide a clearer view of operating performance.<\/p>\n

This improves liquidity analysis<\/strong>, profitability analysis<\/strong>, and overall equity performance<\/strong> evaluation.<\/p>\n

Linking R&D to Valuation<\/h3>\n

R&D is a key driver of future growth, making it critical for equity valuation<\/strong>. By capitalising R&D, analysts can better estimate long-term cash flows and growth potential.<\/p>\n

This is particularly important in growth investing<\/strong>, where future innovation drives value. It also helps in value investing<\/strong>, where hidden assets may not be reflected in financial reports<\/strong>.<\/p>\n

Using valuation methods<\/strong> such as discounted cash flow, analysts incorporate R&D-adjusted figures into financial forecasting<\/strong>. This improves the accuracy of investment insights<\/strong> and strengthens equity research reports<\/strong>.<\/p>\n

Role of AI in R&D Analysis<\/h3>\n

The use of ai for data analysis<\/strong> and ai for equity research<\/strong> is enhancing how analysts evaluate R&D. Advanced financial research tools<\/strong> can analyze trends in R&D spending, innovation output, and market impact.<\/p>\n

With equity research automation<\/strong> and equity search automation<\/strong>, analysts can track how R&D investments translate into market share analysis<\/strong>, trend analysis<\/strong>, and market sentiment analysis<\/strong>.<\/p>\n

An ai report generator<\/strong> can identify patterns in R&D efficiency and highlight companies where spending is likely to generate strong returns. This improves investment insights<\/strong> and supports better risk analysis<\/strong>.<\/p>\n

Risks and Limitations<\/h3>\n

While R&D capitalisation<\/a> improves analysis, it also introduces assumptions. Estimating the useful life of R&D and its future benefits involves uncertainty.<\/p>\n

If assumptions are incorrect, it can affect financial forecasting<\/strong>, equity valuation<\/strong>, and equity performance<\/strong> expectations. For financial advisors<\/strong>, wealth advisors<\/strong>, and financial consultants<\/strong>, this requires careful interpretation.<\/p>\n

R&D outcomes can also be unpredictable. Not all investments lead to successful products or innovations. This increases equity risk<\/strong> and requires strong risk mitigation<\/strong> strategies.<\/p>\n

Geographic and Industry Considerations<\/h3>\n

The importance of R&D varies across industries and regions. Companies in technology and pharmaceuticals rely heavily on innovation, making R&D capitalisation more relevant.<\/p>\n

Geographic exposure<\/strong> and regulatory environments also play a role. Intellectual property protection and innovation ecosystems differ across regions, affecting emerging markets analysis<\/strong> and market risk analysis<\/strong>.<\/p>\n

Changes in macroeconomic outlook<\/strong> or geopolitical factors<\/strong> can also influence R&D effectiveness and valuation.<\/p>\n

Improving Investment Strategy<\/h3>\n

Incorporating R&D capitalisation into investment strategy<\/strong> helps analysts make better decisions. It provides a clearer view of long-term value and supports more accurate portfolio risk assessment<\/strong>.<\/p>\n

For investment analysts<\/strong>, this approach enhances fundamental analysis<\/strong> and strengthens equity analysis<\/strong>. It also improves the quality of equity research reports<\/strong> and supports better decision-making for investors.<\/p>\n

The Future of R&D Capitalisation<\/h3>\n

As innovation becomes a key driver of value, R&D capitalisation will become more important in equity research<\/strong>. Advances in ai data analysis<\/strong>, equity research automation<\/strong>, and financial research tools<\/strong> will improve the accuracy of these adjustments.<\/p>\n

With better data and analytics, analysts will be able to assess R&D effectiveness more precisely, leading to improved equity valuation<\/strong> and stronger investment insights<\/strong>.<\/p>\n

Conclusion<\/h3>\n

Research and development capitalisation is a critical adjustment in modern equity research<\/strong>. By treating R&D as an investment rather than an expense, analysts can better reflect true business value and improve equity valuation<\/strong>.<\/p>\n

Combining financial modeling<\/strong>, fundamental analysis<\/strong>, and ai for data analysis<\/strong> enables more accurate and insightful equity research reports<\/strong>. Platforms like GenRPT Finance<\/a> support this process by integrating equity research automation<\/strong> and advanced analytics, helping analysts deliver deeper and more reliable investment research<\/strong>.<\/p>\n

FAQs<\/h3>\n

What is R&D capitalisation?<\/strong>
It is the process of treating R&D spending as a long-term investment rather than an immediate expense.<\/p>\n

Why do analysts capitalise R&D?<\/strong>
To better reflect the long-term value of innovation in equity valuation<\/strong> and investment insights<\/strong>.<\/p>\n

How does it affect ratio analysis?<\/strong>
It adjusts asset and earnings figures, making ratios more accurate.<\/p>\n

What are the risks?<\/strong>
It involves assumptions about future benefits, which may not always materialize.<\/p>\n

How does AI help in R&D analysis?<\/strong>
AI uses ai data analysis<\/strong> and equity research automation<\/strong> to track trends and improve evaluation.<\/p>\n","protected":false},"excerpt":{"rendered":"

Research and development capitalisation means treating R&D spending as a long-term investment rather than a short-term expense, and in equity research it is used by analysts to better reflect true business value, improve equity valuation, and generate more accurate investment insights. Why R&D Is Expensed in Financial Accounting Under standard financial accounting, most R&D costs […]<\/p>\n","protected":false},"author":1,"featured_media":3539,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,3,2],"tags":[],"class_list":["post-3540","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-agentic-ai","category-artificial-intelligence","category-equity-research"],"yoast_head":"\nResearch and Development Capitalisation - Agentic AI-Powered Equity Research & Risk Reports | GenRPT Finance<\/title>\n<meta name=\"description\" content=\"Learn how R&D capitalisation improves equity research by adjusting financials to reflect true innovation-driven value and better investment insights.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Research and Development Capitalisation - Agentic AI-Powered Equity Research & Risk Reports | GenRPT Finance\" \/>\n<meta property=\"og:description\" content=\"Learn how R&D capitalisation improves equity research by adjusting financials to reflect true innovation-driven value and better investment insights.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/\" \/>\n<meta property=\"og:site_name\" content=\"Agentic AI-Powered Equity Research & Risk Reports | GenRPT Finance\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-04T04:08:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-04T05:30:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genrptfinance.com\/blogs\/wp-content\/uploads\/2026\/05\/research_and_development_capitalisation.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"401\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"GenRPT Finance\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"GenRPT Finance\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/\"},\"author\":{\"name\":\"GenRPT Finance\",\"@id\":\"https:\/\/genrptfinance.com\/blogs\/#\/schema\/person\/ee71e0e5e9f66ba6ade9ba19e3a2df5d\"},\"headline\":\"Research and Development Capitalisation\",\"datePublished\":\"2026-05-04T04:08:28+00:00\",\"dateModified\":\"2026-05-04T05:30:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/\"},\"wordCount\":1079,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genrptfinance.com\/blogs\/wp-content\/uploads\/2026\/05\/research_and_development_capitalisation.jpg\",\"articleSection\":[\"Agentic AI\",\"Artificial Intelligence\",\"Equity Research\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/\",\"url\":\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/\",\"name\":\"Research and Development Capitalisation - Agentic AI-Powered Equity Research & Risk Reports | GenRPT Finance\",\"isPartOf\":{\"@id\":\"https:\/\/genrptfinance.com\/blogs\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genrptfinance.com\/blogs\/wp-content\/uploads\/2026\/05\/research_and_development_capitalisation.jpg\",\"datePublished\":\"2026-05-04T04:08:28+00:00\",\"dateModified\":\"2026-05-04T05:30:11+00:00\",\"author\":{\"@id\":\"https:\/\/genrptfinance.com\/blogs\/#\/schema\/person\/ee71e0e5e9f66ba6ade9ba19e3a2df5d\"},\"description\":\"Learn how R&D capitalisation improves equity research by adjusting financials to reflect true innovation-driven value and better investment insights.\",\"breadcrumb\":{\"@id\":\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#primaryimage\",\"url\":\"https:\/\/genrptfinance.com\/blogs\/wp-content\/uploads\/2026\/05\/research_and_development_capitalisation.jpg\",\"contentUrl\":\"https:\/\/genrptfinance.com\/blogs\/wp-content\/uploads\/2026\/05\/research_and_development_capitalisation.jpg\",\"width\":600,\"height\":401,\"caption\":\"Research and Development Capitalisation: How Different Accounting Treatments Create Incomparable Financial Statements Across Companies\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genrptfinance.com\/blogs\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research and Development Capitalisation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genrptfinance.com\/blogs\/#website\",\"url\":\"https:\/\/genrptfinance.com\/blogs\/\",\"name\":\"Agentic AI-Powered Equity Research & Risk Reports | GenRPT Finance\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genrptfinance.com\/blogs\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/genrptfinance.com\/blogs\/#\/schema\/person\/ee71e0e5e9f66ba6ade9ba19e3a2df5d\",\"name\":\"GenRPT Finance\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/53f16f1eec27f39d36c585c7d710fa4ceceb521e044d2eb785b6c35c901e4adb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/53f16f1eec27f39d36c585c7d710fa4ceceb521e044d2eb785b6c35c901e4adb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/53f16f1eec27f39d36c585c7d710fa4ceceb521e044d2eb785b6c35c901e4adb?s=96&d=mm&r=g\",\"caption\":\"GenRPT Finance\"},\"sameAs\":[\"https:\/\/genrptfinance.com\/blogs\"],\"url\":\"https:\/\/genrptfinance.com\/blogs\/author\/genrptfinance-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Research and Development Capitalisation - Agentic AI-Powered Equity Research & Risk Reports | GenRPT Finance","description":"Learn how R&D capitalisation improves equity research by adjusting financials to reflect true innovation-driven value and better investment insights.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/","og_locale":"en_US","og_type":"article","og_title":"Research and Development Capitalisation - Agentic AI-Powered Equity Research & Risk Reports | GenRPT Finance","og_description":"Learn how R&D capitalisation improves equity research by adjusting financials to reflect true innovation-driven value and better investment insights.","og_url":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/","og_site_name":"Agentic AI-Powered Equity Research & Risk Reports | GenRPT Finance","article_published_time":"2026-05-04T04:08:28+00:00","article_modified_time":"2026-05-04T05:30:11+00:00","og_image":[{"width":600,"height":401,"url":"https:\/\/genrptfinance.com\/blogs\/wp-content\/uploads\/2026\/05\/research_and_development_capitalisation.jpg","type":"image\/jpeg"}],"author":"GenRPT Finance","twitter_card":"summary_large_image","twitter_misc":{"Written by":"GenRPT Finance","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#article","isPartOf":{"@id":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/"},"author":{"name":"GenRPT Finance","@id":"https:\/\/genrptfinance.com\/blogs\/#\/schema\/person\/ee71e0e5e9f66ba6ade9ba19e3a2df5d"},"headline":"Research and Development Capitalisation","datePublished":"2026-05-04T04:08:28+00:00","dateModified":"2026-05-04T05:30:11+00:00","mainEntityOfPage":{"@id":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/"},"wordCount":1079,"commentCount":0,"image":{"@id":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#primaryimage"},"thumbnailUrl":"https:\/\/genrptfinance.com\/blogs\/wp-content\/uploads\/2026\/05\/research_and_development_capitalisation.jpg","articleSection":["Agentic AI","Artificial Intelligence","Equity Research"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/","url":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/","name":"Research and Development Capitalisation - Agentic AI-Powered Equity Research & Risk Reports | GenRPT Finance","isPartOf":{"@id":"https:\/\/genrptfinance.com\/blogs\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#primaryimage"},"image":{"@id":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#primaryimage"},"thumbnailUrl":"https:\/\/genrptfinance.com\/blogs\/wp-content\/uploads\/2026\/05\/research_and_development_capitalisation.jpg","datePublished":"2026-05-04T04:08:28+00:00","dateModified":"2026-05-04T05:30:11+00:00","author":{"@id":"https:\/\/genrptfinance.com\/blogs\/#\/schema\/person\/ee71e0e5e9f66ba6ade9ba19e3a2df5d"},"description":"Learn how R&D capitalisation improves equity research by adjusting financials to reflect true innovation-driven value and better investment insights.","breadcrumb":{"@id":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#primaryimage","url":"https:\/\/genrptfinance.com\/blogs\/wp-content\/uploads\/2026\/05\/research_and_development_capitalisation.jpg","contentUrl":"https:\/\/genrptfinance.com\/blogs\/wp-content\/uploads\/2026\/05\/research_and_development_capitalisation.jpg","width":600,"height":401,"caption":"Research and Development Capitalisation: How Different Accounting Treatments Create Incomparable Financial Statements Across Companies"},{"@type":"BreadcrumbList","@id":"https:\/\/genrptfinance.com\/blogs\/research-and-development-capitalisation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genrptfinance.com\/blogs\/"},{"@type":"ListItem","position":2,"name":"Research and Development Capitalisation"}]},{"@type":"WebSite","@id":"https:\/\/genrptfinance.com\/blogs\/#website","url":"https:\/\/genrptfinance.com\/blogs\/","name":"Agentic AI-Powered Equity Research & Risk Reports | GenRPT Finance","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genrptfinance.com\/blogs\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/genrptfinance.com\/blogs\/#\/schema\/person\/ee71e0e5e9f66ba6ade9ba19e3a2df5d","name":"GenRPT Finance","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/53f16f1eec27f39d36c585c7d710fa4ceceb521e044d2eb785b6c35c901e4adb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/53f16f1eec27f39d36c585c7d710fa4ceceb521e044d2eb785b6c35c901e4adb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/53f16f1eec27f39d36c585c7d710fa4ceceb521e044d2eb785b6c35c901e4adb?s=96&d=mm&r=g","caption":"GenRPT Finance"},"sameAs":["https:\/\/genrptfinance.com\/blogs"],"url":"https:\/\/genrptfinance.com\/blogs\/author\/genrptfinance-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/genrptfinance.com\/blogs\/wp-json\/wp\/v2\/posts\/3540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genrptfinance.com\/blogs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genrptfinance.com\/blogs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genrptfinance.com\/blogs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genrptfinance.com\/blogs\/wp-json\/wp\/v2\/comments?post=3540"}],"version-history":[{"count":3,"href":"https:\/\/genrptfinance.com\/blogs\/wp-json\/wp\/v2\/posts\/3540\/revisions"}],"predecessor-version":[{"id":3594,"href":"https:\/\/genrptfinance.com\/blogs\/wp-json\/wp\/v2\/posts\/3540\/revisions\/3594"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genrptfinance.com\/blogs\/wp-json\/wp\/v2\/media\/3539"}],"wp:attachment":[{"href":"https:\/\/genrptfinance.com\/blogs\/wp-json\/wp\/v2\/media?parent=3540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genrptfinance.com\/blogs\/wp-json\/wp\/v2\/categories?post=3540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genrptfinance.com\/blogs\/wp-json\/wp\/v2\/tags?post=3540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}